From the impact of Obamacare to cutting-edge research, biotech buyouts to FDA decisions, The Motley Fool's health-care team sits down each week to discuss the most fascinating developments in health care and their implications for long-term investors. In this week's edition, the team talks about the coming trend of penalizing unhealthy employees, the importance of drug branding, the avian flu outbreak, one stock investors need to watch, and more.
This Week in Health Care
By Max Macaluso and Dave Williamson
-
Apr 14, 2013 at 1:45PM
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
The Motley Fool's weekly health-care show.
Related Articles
Why Novavax Is Up More Than 18% Today
Why 23andMe Stock Was Lagging the Market Today
Why Iovance Biotherapeutics Was Halved Today
3 Unstoppable Stocks That Are Higher Than Before the Market Correction
Why Moderna Stock Is Jumping Today
Motley Fool Returns
Market-beating stocks from our award-winning service.
Stock Advisor Returns
344%
344%
S&P 500 Returns
120%
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/27/2022.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Cumulative Growth of a $10,000 Investment in Stock Advisor
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Our Most Popular Articles
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.